MARKET

CLGN

CLGN

Collplant Biotechnologies Ltd
NASDAQ
1.410
-0.120
-7.84%
Closed 16:00 12/17 EST
OPEN
1.655
PREV CLOSE
1.530
HIGH
1.655
LOW
1.410
VOLUME
32.49K
TURNOVER
0
52 WEEK HIGH
4.980
52 WEEK LOW
1.310
MARKET CAP
18.01M
P/E (TTM)
-1.3798
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CLGN last week (1208-1212)?
Weekly Report · 3d ago
Weekly Report: what happened at CLGN last week (1201-1205)?
Weekly Report · 12/08 10:25
Weekly Report: what happened at CLGN last week (1124-1128)?
Weekly Report · 12/01 10:20
Collplant Biotechnologies Price Target Maintained With a $12.00/Share by D. Boral Capital
Dow Jones · 11/28 14:15
Collplant Biotechnologies Is Maintained at Buy by D. Boral Capital
Dow Jones · 11/28 14:15
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target
Benzinga · 11/28 14:06
CollPlant Biotechnologies Reports Q3 2025 Financial Results
TipRanks · 11/27 03:57
CollPlant Biotechnologies Announces Annual and Extraordinary General Meeting for December 2025
TipRanks · 11/26 21:48
More
About CLGN
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Webull offers Collplant Biotechnologies Ltd - ADR stock information, including NASDAQ: CLGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLGN stock methods without spending real money on the virtual paper trading platform.